We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.

I Agree

You are here: Industry Insights > ImaginAb

News List

AZ recruits ImaginAb in CD8 ImmunoPET deal pharmatimes
March 31, 2020
AstraZeneca has revealed plans to signed a multi-year non-exclusive license agreement with ImaginAb, in order to license the latter’s ImaginAb’s CD8 ImmunoPET technology.
ImaginAb teams up with Roche for multiple cancer clinical trials biospectrumasia
July 10, 2019
Roche will use ImaginAb's novel minibody CD8 T cell imaging agent in immuno-oncology clinical trials for multiple types of cancers
ImaginAb, CPDC enter into an agreement biospectrumasia
September 03, 2018
Under the terms of the agreement, CPDC will manufacture and distribute Zr-89 IAB22M2C to ImaginAb's Phase II clinical trial sites, Investigator Initiated Trial sites and to sites involved in studies being conducted in collaboration and partnership with ph